Beijing, China

Guangqiang Xia


 

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Innovations by Guangqiang Xia in Medicinal Chemistry

Introduction

Guangqiang Xia is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antiviral medications. With a total of two patents to his name, his work focuses on optically pure dihydropyrimidine compounds.

Latest Patents

Guangqiang Xia's latest patents include innovative compounds that are crucial for the treatment and prevention of viral diseases. The first patent describes optically pure dihydropyrimidine compounds and their uses for preparing a medicament aimed at treating and preventing type B hepatitis. This invention outlines a process for preparing the optically pure compound and its application as a medicament. The second patent also focuses on dihydropyrimidine compounds, detailing their use in the preparation of medicaments for treating and preventing antiviral diseases, specifically targeting type B hepatitis.

Career Highlights

Guangqiang Xia is associated with Beijing Molecule Science and Technology Co., Ltd., where he continues to advance his research in medicinal chemistry. His work has garnered attention for its potential impact on public health, particularly in the realm of viral disease treatment.

Collaborations

Some of his notable coworkers include Song Li and Guoming Zhao, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Guangqiang Xia's contributions to the field of medicinal chemistry through his innovative patents highlight the importance of research in developing effective treatments for viral diseases. His work continues to pave the way for advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…